Urinary Tract Infection (UTI) Treatment Market with Covid-19 Pandemic Analysis, Growth Rate, New Trend Analysis Forecast To 2029

1
Urinary Tract Infection (UTI) Treatment
Market 2021, Swot Analysis, Key Development And
Forecasts Till 2029

• March 2021

Report Id REP-GB-1340 Published On
2019-06-24 Category Healthcare, Pharmaceuticals
Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)

• Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)

• Identifying key opinion leaders
• Questionnaire design
• In-depth interviews
• Coverage across value chain

• Key industry experts
• Channel study
• Developments
• Market dynamics
• Products
• Conclusions

SOLUTION

• Market participants
• Key strengths
• Product portfolio
• Mapping as per value chain
• Key focus segments

Primary Research
Secondary Research
Paid Publications

• Linkedin
• Zoominfo
• Salesforce
• Avention

• Factiva
• GBI
• Genios
• Meltwater

• Company websites
• Company annual reports
• White papers
• Financial reports

includes sources of databases
4
Urinary Tract Infection (UTI) Treatment Market
Analysis
 The increasing prevalence of urinary tract
infection (UTI) and growth in the number of
prescription of quinolones antibiotics is
expected to fuel the growth of the urinary tract
infection treatment market. According to a new
study published by Future Market Insights (FMI),
the global urinary tract infection treatment
market revenues will grow at a mere 2 CAGR
between 2019 and 2029. Launch of New Antibiotics
for Bacterial Infections to Sustain
Revenues Increase in the number of research and
development initiatives for the developing novel
therapeutics has led to the launch of new drugs
into the urinary tract infection treatment
market. Manufacturers are currently focusing on
expanding their pipeline portfolio for the
treatment of bacterial infections. Moreover,
regulatory bodies such as FDA have accelerated
the approval process of drugs. Recently,
in August 2018, Melinta Therapeutics announced
the launch of Vabomere (meropenem and
vaborbactam) for patients who require treatment
for complicated urinary tract infection.
Similarly, one more drug has been approved by FDA
in June 2018, Zemdri by Achaogen, Inc., for the
treatment of adults suffering from Complicated
Urinary Tract Infection (cUTI). Increase in the
launch and approval of novel therapeutics for the
treatment of bacterial infections is expected to
contribute to the growth of the urinary tract
infection treatment market. Request a Sample
Report with Table of Contents and
Figures https//www.futuremarketinsights.com/repo
rts/sample/rep-gb-1340
5
Urinary Tract Infection (UTI) Treatment Market
Analysis
Quinolones, the broad spectrum antibiotics
effective against a wide range of bacterial
disease, have bactericidal activity that enables
them to penetrate deep into the tissue. Their
excellent bioavailability is a plus point. In
addition, they have favourable tolerability and
safety profile. Moreover, they have significant
antimicrobial activity. Thus, quinolones are most
preferred for the treatment of urinary tract
infection. Some of the widely used quinolones for
the prevention of bacterial infection include
ciprofloxacin (Cipro), ofloxacin (Floxin),
norfloxacin (Noroxin), and others. Quinolones are
mostly favored over trimethoprim-sulfamethoxazole
(TMP-SMX) for the treatment of uncomplicated
urinary tract infections owing to the increasing
resistance of bacteria towards antibiotics such
as trimethoprim-sulfamethoxazole, beta lactam
antibiotics, and others
Preview analysis of Urinary Tract Infection (UTI)
Treatment Market Sustained Use of Urinary
Catheters Offering the Necessary Push Global
Industry Analysis 2014-2018 and Opportunity
Assessment 2019-2029 https//www.futuremarketinsi
ghts.com/reports/urinary-tract-infections-market
6
Urinary Tract Infection (UTI) Treatment Market
Analysis
Europe Remains Major Revenue Contributor Europe ho
lds a considerable revenue share in the UTI
treatment market. The rising prevalence of
urinary tract infection among the population and
increasing hospital visits are among factors that
are likely to propel the growth of the urinary
tract infection treatment market. It is estimated
that the urinary tract infection treatment market
will create an incremental opportunity worth
nearly US 9 Mn between 2019 and 2029. Quinolones
is anticipated to boost the growth of the urinary
tract infection treatment market owing to the
increasing prescription and high effectivity as
antimicrobial antibiotics. Demand from Retail
Pharmacies to Register High Growth The global
urinary tract infection treatment market has been
segmented on the basis of drug class, indication,
and distribution channel. On the basis of drug
class, the urinary tract infection treatment
market has been segmented into Penicillin
Combinations, Quinolones, Cephalosporin,
Aminoglycoside Antibiotics, Sulphonamides
(Sulfamethoxazole Trimethoprim), Azoles and
Amphotericin B, Tetracycline (Doxycycline),
Nitrofurans (Nitrofurantoin), and others. In
terms of revenue, the quinolones segment is
expected to hold a major share of the urinary
tract infection treatment market during the
forecast period since it is widely prescribed and
has proven to be safe and effective for
antimicrobial use. Buy this report
_at_ https//www.futuremarketinsights.com/checkout/13
40
7
Urinary Tract Infection (UTI) Treatment Market
Analysis
Based on indication, the urinary tract infection
treatment market has been segmented into
complicated urinary tract infection and
uncomplicated urinary tract infection. On the
basis of distribution channel, the urinary tract
infection treatment market has been categorised
into hospital pharmacies, gynaecology urology
clinics, drug stores, retail pharmacies, and
online drug stores. The retail pharmacies segment
is expected to exhibit high revenue growth in the
urinary tract infection treatment market owing to
the easy availability of antibiotics. Key
Companies in Urinary Tract Infection Treatment
Market The report studies some of the key
companies operating in the urinary tract
infection treatment market, such as Bayer AG,
GlaxoSmithKline Pharmaceuticals Ltd., Pfizer,
Allergan Plc, Almirall SA, Bristol-Myers Squibb,
and Merck Co., Inc. For more insights on the
competitive landscape and other facets shaping
the growth of UTI treatment market.
8
Urinary Tract Infection (UTI) Treatment Market
Analysis
Our advisory services are aimed at helping you
with specific, customized insights that are
relevant to your specific challenges. Let us know
about your challenges and our trusted advisors
will connect with you https//www.futuremarketins
ights.com/askus/rep-gb-1340 More
from Healthcare, Pharmaceuticals and Medical
devices Market Insights Market Intelligence Fluo
rescence Spectroscopy Market Analysis Home Sleep
Screening Devices Demand Growth Assessment Memory
Enhancing Drugs Market Analysis
9
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)